. . . . . . . . . . . . "p(HGNC:TGFB1) -> path(MESHD:Hypertrophy)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Pharmacologic inhibition of FAK or expression of kinase-deficient FAK, mutated by substituting Tyr-397 with Phe, inhibit TGF-beta1-induced alpha-smooth muscle actin expression, stress fiber formation, and cellular hypertrophy." . . "Selventa" . . . . "2014-07-03T14:31:58.232+02:00"^^ . . .